agrilintide is a long-acting amylin analogue investigated for effects on appetite, food intake, and metabolic regulation. It remains an investigational drug rather than an established routine medicine.

The Hubio Pharm listing identifies a 10 mg strength. The exact dosage form, formulation, package size, and storage requirements are not established from the supplied information.

FDA has treated cagrilintide products marketed for human use as unapproved new drugs in enforcement actions. Product identity and regulatory status should therefore be verified carefully